Skip Navigation


European Journal of Echocardiography Advance Access originally published online on February 27, 2009
European Journal of Echocardiography 2009 10(4):562-566; doi:10.1093/ejechocard/jep001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
10/4/562    most recent
jep001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dini, F. L.
Right arrow Articles by De Tommasi, S. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dini, F. L.
Right arrow Articles by De Tommasi, S. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Value of tissue Doppler imaging for risk stratification of patients with chronic systolic heart failure with or without restrictive mitral flow

Frank L. Dini1,2,*, Fabio Lattanzi1, Paolo Fontanive1, Gian Marco Rosa2 and Salvatore Mario De Tommasi1

1 Unità Malattie Cardiovascolari 2, Ospedale S. Chiara, Azienda Ospedaliera-Universitaria Pisana, Via Roma, 67, 56126 Pisa, Italy
2 Dipartimento di Medicina Interna e Specialità Mediche, Azienda Ospedaliera-Universitaria San Martino, Genova

Received 9 July 2008; accepted after revision 11 January 2009; online publish-ahead-of-print 27 February 2009.

* Corresponding author. Tel: +39 050 992355; fax: +39 050 993114. E-mail address: f.dini{at}ao-pisa.toscana.it


   Abstract

Aims: The aim of this study was to assess the prognostic value of tissue Doppler imaging (TDI) in patients with chronic systolic heart failure (HF) with or without restrictive mitral flow (RMF).

Methods and results: Echocardiograms were obtained in 378 patients with chronic systolic HF [ejection fraction (EF) ≤ 45%] in sinus rhythm. Restrictive mitral flow was defined by an E wave deceleration time (EDT) ≤ 140 ms. Tissue Doppler imaging early (Em) diastolic and systolic (Sm) velocities were measured at the mitral annulus. Patients were followed-up for a median of 32 months. Endpoints were all-cause mortality and the combination of death or HF hospitalization. Mean left ventricular EF was 32 ± 8%. Restrictive mitral flow and TDI annular velocities were all univariate predictors of the endpoints. Ejection fraction <25% was the only multivariate predictor of all-cause mortality. E wave deceleration time and Em < 8 cm/s were independently associated with the combined endpoint of death or HF hospitalization. At 48 months, survival was 61% in patients with RMF and 82% in patients with non-RMF (log-rank: 21.6; P < 0.0001). When patients were stratified according to Em at or above 8 cm/s or below 8 cm/s, those with RMF and Em < 8 cm/s exhibited the worst survival (log-rank: 27.16; P < 0.0001). Patients with Sm ≤ 6 cm/s had a 58% survival rate, whereas it was 82% in patients with Sm > 6 cm/s (log-rank: 12.73; P = 0.0004).

Conclusion: Doppler annular velocities provided useful information for prognostication of patients with systolic HF. Particularly, categorization of patients according to Em velocities allowed us to further stratify patients with RMF and non-RMF.

Keywords: Heart failure; Tissue Doppler imaging; Prognosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.